Found 17 matching trials
A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma PHASE2 The purpose of this study is to compare the relapse free survival and overa...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Inserting a laboratory-treated gene into a person's white blood ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
REO13 Melanoma With of Without GM-CSF PHASE1 Open-label, non-randomised, single centre study which will assess the prese...
Show More Location
Multiple Locations
Learn More & Join Trial
SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002) PHASE2 This is a Phase II/III randomized, controlled, multicenter, open-label stud...
Show More Location
Multiple Locations
Learn More & Join Trial
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery PHASE2 RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Show More Location
Unversity of Nebraska Medical Center
Learn More & Join Trial
Cognitive Effects of Interferon in Patients With Melanoma N/A Interferon alpha is the only approved adjuvant biologic therapy for individ...
Show More Location
University of Arizona
Learn More & Join Trial
A Trial of FANG⢠Vaccine for Participants With Ovarian Cancer PHASE2 This was a clinical trial for women with ovarian cancer scheduled to have a...
Show More Location
Florida Cancer Specialists
Learn More & Join Trial
HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma PHASE3 This is a a multicenter, randomized, controlled, phase III trial comparing ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Drugs used in chemotherapy such as cyclophosphamide and fludarab...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer PHASE1 This is a Phase 1b clinical trial to assess the safety and tolerability of ...
Show More Location
Southern Illinois University School of Medicine
Learn More & Join Trial